Signet Therapeutics
Shenzhen
About Signet Therapeutics
Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $40.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
- Website: signettx.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/signet-therapeutics-47966 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.